Skip to main content
. 2019 May 7;4(7):995–1003. doi: 10.1016/j.ekir.2019.04.018

Figure 2.

Figure 2

Kidney disease severity in the extended Toronto Genetic Epidemiology Study of Polycystic Kidney Disease cohort. Proportion of patients with mild, intermediate or indeterminate, or severe kidney disease (a). Five patients had conflicting assessment of kidney disease severity (i.e., evidence of both mild and severe disease; see Supplementary Table S1). Venn diagrams showing criteria used for defining the severe (b) and mild (c) cases. eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; Mayo, Mayo Clinic Imaging Classification.